XML 44 R13.htm IDEA: XBRL DOCUMENT v3.3.0.814
Purchase of Intellectual Property from Seachaid Pharmaceuticals, Inc
9 Months Ended
Sep. 30, 2015
Purchase Of Intellectual Property [Abstract]  
Purchase of Intellectual Property from Seachaid Pharmaceuticals, Inc

8. PURCHASE OF INTELLECTUAL PROPERTY FROM SEACHAID PHARMACEUTICALS, INC.

In May 2014, the Company entered into an asset purchase agreement with Seachaid Pharmaceuticals, Inc., or Seachaid, whereby the Company purchased intellectual property related to its antifungal product candidates, CD101 IV and CD101 topical. As consideration for the assets acquired, the Company issued 703,092 shares of common stock to Seachaid with an estimated fair value of $1.6 million.